Kalbe Farma Tbk PT banner

Kalbe Farma Tbk PT
IDX:KLBF

Watchlist Manager
Kalbe Farma Tbk PT Logo
Kalbe Farma Tbk PT
IDX:KLBF
Watchlist
Price: 865 IDR -4.95% Market Closed
Market Cap: Rp40.5T

Kalbe Farma Tbk PT
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kalbe Farma Tbk PT
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Kalbe Farma Tbk PT
IDX:KLBF
Free Cash Flow
Rp2.5T
CAGR 3-Years
83%
CAGR 5-Years
-4%
CAGR 10-Years
5%
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Free Cash Flow
Rp914.9B
CAGR 3-Years
N/A
CAGR 5-Years
11%
CAGR 10-Years
6%
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Free Cash Flow
Rp93.8B
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
-6%
Soho Global Health Tbk PT
IDX:SOHO
Free Cash Flow
Rp837.4B
CAGR 3-Years
38%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Pyridam Farma Tbk PT
IDX:PYFA
Free Cash Flow
-Rp532.6B
CAGR 3-Years
-135%
CAGR 5-Years
-140%
CAGR 10-Years
N/A
Kimia Farma Tbk PT
IDX:KAEF
Free Cash Flow
Rp101B
CAGR 3-Years
N/A
CAGR 5-Years
-26%
CAGR 10-Years
14%
No Stocks Found

Kalbe Farma Tbk PT
Glance View

Kalbe Farma Tbk PT is a renowned pharmaceutical powerhouse rooted in Indonesia, rooted in a rich history that traces back to 1966. The company has evolved from a humble startup into a multifaceted entity with a robust portfolio, making it a vital player in the health and wellness sector across Southeast Asia. The company operates across four main business divisions: prescription pharmaceuticals, consumer health products, nutritionals, and distribution & logistics. By strategically linking these divisions, Kalbe Farma masterfully balances scientific innovation with market accessibility, ensuring a wide reach and varied product offering. This diversification not only broadens its revenue streams but also mitigates risk, securing its foothold in the competitive pharmaceutical landscape. At the core of Kalbe Farma’s business model lies a commitment to research and development, which fuels its cutting-edge product innovations and enhances its competitive edge. The company dedicates substantial resources to developing new medicines and health products, constantly seeking to address emerging health concerns. Moreover, its extensive distribution network fortifies its market presence, comprising a domestic distribution arm that penetrates even the farthest reaches of the Indonesian archipelago. This network ensures that Kalbe's products are widely available, amplifying their market penetration and revenue. Additionally, Kalbe embraces partnerships and collaborations to enhance its research capabilities and expand its product offerings, fostering an ecosystem where innovation and accessibility coexist harmoniously, thereby empowering its bottom line.

KLBF Intrinsic Value
1 375.51 IDR
Undervaluation 37%
Intrinsic Value
Price Rp865

See Also

What is Kalbe Farma Tbk PT's Free Cash Flow?
Free Cash Flow
2.5T IDR

Based on the financial report for Dec 31, 2025, Kalbe Farma Tbk PT's Free Cash Flow amounts to 2.5T IDR.

What is Kalbe Farma Tbk PT's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
5%

Over the last year, the Free Cash Flow growth was -30%. The average annual Free Cash Flow growth rates for Kalbe Farma Tbk PT have been 83% over the past three years , -4% over the past five years , and 5% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett